Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-05-16
DOI
10.3389/fmicb.2023.1137811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- (2022) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
- (2022) Fred C. Tenover et al. Emerging Microbes & Infections
- Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
- (2022) Alba Bergas et al. Microbiology Spectrum
- Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne blaKPC-2 and Virulence-Related Genes
- (2021) Yanyan Hu et al. mSystems
- Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China
- (2021) Kai Yang et al. Journal of Global Antimicrobial Resistance
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
- (2021) Dan Reynolds et al. DRUGS
- Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing P. aeruginosa Sequence Type 463, Associated With High Mortality Rates in China: A Retrospective Cohort Study
- (2021) Hangbin Hu et al. Frontiers in Cellular and Infection Microbiology
- Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia
- (2020) Yuanqi Zhao et al. CLINICAL INFECTIOUS DISEASES
- A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections
- (2019) Qingyi Shi et al. Antimicrobial Resistance and Infection Control
- Resilience of the Pitt Bacteremia Score: Three Decades and Counting
- (2019) Majdi N Al-Hasan et al. CLINICAL INFECTIOUS DISEASES
- High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
- (2019) Gertrudis Horna et al. Scientific Reports
- Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
- (2019) Juan P. Horcajada et al. CLINICAL MICROBIOLOGY REVIEWS
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
- (2018) Shuang Li et al. Infection and Drug Resistance
- Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010–15): antibiotics do matter
- (2017) Matthaios Papadimitriou-Olivgeris et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
- (2017) Chia-Hsin Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia
- (2017) Poh-Chang Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Global Dissemination ofblaKPCinto Bacterial Species beyond Klebsiella pneumoniae andIn VitroSusceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
- (2016) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano
- (2016) Sandra Liliana Valderrama et al. Biomedica
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Impact of hyperglycemia on outcomes of patients with Pseudomonas aeruginosa bacteremia
- (2016) Twisha S. Patel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites
- (2016) Michelle A. Barron et al. SpringerPlus
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
- (2015) Jonathan C. Cho et al. PHARMACOTHERAPY
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
- (2013) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- P. aeruginosa bloodstream infections among hematological patients: an old or new question?
- (2012) Chiara Cattaneo et al. ANNALS OF HEMATOLOGY
- Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy
- (2012) Felipe F. Tuon et al. Brazilian Journal of Infectious Diseases
- Clinical Characteristics and Risk Factors for Mortality in Patients with Bacteremia Caused by Pseudomonas aeruginosa
- (2012) Tetsuya Horino et al. INTERNAL MEDICINE
- A model to predict mortality following Pseudomonas aeruginosa bacteremia
- (2011) Elizabeth B. Hirsch et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome
- (2011) Eun-Jeong Joo et al. Microbial Drug Resistance
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started